Built by regulatory professionals with more than 25 years of industry experience, Gulfstream Intelligence connects regulatory intelligence, global labeling, gap assessment, health authority preparation, submission planning and regulatory document analysis in one platform.
WELLINGTON, Fla., August 13, 2026 — GulfstreamIntelligence today announced the launch of its regulatory intelligence andexecution platform built specifically for pharmaceutical, biotechnology andlife science organizations.
Developed by Gulfstream Life Science and created byregulatory professionals with more than 25 years of experience in the pharmaceuticaland biotechnology industry, Gulfstream Intelligence grew out of firsthandexperience managing global development programs, health authority interactions,submissions, labeling, regulatory strategy and the day to day challengesregulatory teams face.
Regulatory teams have access to more information and moretechnology than ever before, but much of their work remains disconnected.Regulatory intelligence may live in one system, submission plans in another,labeling in separate documents and spreadsheets, while health authoritypreparation, gap assessments and program decisions are managed through email,presentations and individual files.
Important context can be lost along the way.
Gulfstream Intelligence was built to bring that worktogether and help regulatory professionals move from finding information tounderstanding what it means for a program and determining what needs to happennext.
One Platform for Regulatory Intelligence and Execution
Gulfstream Intelligence brings together several coreregulatory functions within one connected environment.
Global Regulatory Intelligence & Policy
Monitor guidance, legislation, policy changes and health authority developmentsacross major global markets and understand how those changes may affectdevelopment programs.
Global Labeling
Support the development and lifecycle management of global product labeling,including Core Data Sheets and regional labels such as the U.S. PrescribingInformation, EU Summary of Product Characteristics and Canadian Product Monograph.Teams can compare regional labeling, identify differences, evaluate new safetyand efficacy information and maintain greater consistency between global andlocal labeling positions.
Global Regulatory Gap Assessments
Evaluate programs and regulatory documentation against regional healthauthority expectations to identify gaps, risks and actions that may be neededbefore an interaction or submission.
Health Authority Preparation & Simulation
Prepare for meetings and interactions with FDA, EMA, MHRA, PMDA, Health Canadaand other global authorities by identifying likely questions, areas of concernand issues that may require additional justification.
Submission Planning & Critical Path Management
Develop structured submission plans, timelines, dependencies and deliverablesfor INDs, BLAs, NDAs, MAAs and other regulatory milestones while maintainingvisibility into activities that may affect the submission timeline.
Regulatory Document Intelligence
Review regulatory documents to identify inconsistencies, missing information,potential risks and areas that may require additional attention.
Decision Ready Deliverables
Turn regulatory analysis into structured reports, summaries and editablepresentations that can be shared with regulatory teams, development teams andleadership.
Connecting Regulatory Information to Action
The goal is to maintain the connection between theregulatory source, the professional interpretation of that information, itsimpact on the development program, the actions that result from it and thefinal regulatory deliverable.
“The problem is not simply finding regulatory information.It is what happens after the information is found,” said Scott Morvay, Founderof Gulfstream Intelligence. “After more than 25 years working in regulatory affairs,we have seen how quickly important context can become disconnected asinformation moves between systems, documents and teams. We built Gulfstreamaround the way regulatory professionals actually work, from understanding anissue to deciding what it means for the program and ultimately doing somethingabout it.”
For larger pharmaceutical organizations, GulfstreamIntelligence provides a way to maintain greater continuity across programs,functions, regions and health authorities. Regulatory intelligence, labeling,health authority preparation, submission planning and document review canremain connected rather than becoming separate workstreams managed acrossmultiple systems.
For emerging and mid sized biotechnology companies,Gulfstream provides many of those same capabilities in one environment. Thiscan be particularly valuable for regulatory teams managing broadresponsibilities with limited internal resources.
Built by RegulatoryProfessionals for Regulatory Professionals
Gulfstream Intelligence was not created by taking ageneral technology platform and adapting it to regulatory affairs. It was builtfrom the experience of regulatory professionals who understand how developmentprograms evolve, how health authority expectations affect strategy and howregulatory decisions are carried through to submissions and labeling.
That experience shaped both the platform and the way itscapabilities work together.
Gulfstream uses artificial intelligence to assist withresearch, comparison, analysis, planning and drafting while keeping qualifiedregulatory professionals responsible for reviewing information, interpretingregulatory requirements and making regulatory decisions.
“AI can help us work faster, but regulatory affairs is notsimply an information problem,” Morvay said. “Experience matters. Judgmentmatters. Understanding the development program matters. Gulfstream was built togive regulatory professionals better tools to apply that experience.”
The platform does not replace professional judgment, providelegal advice or independently submit materials to health authorities.
Supporting the RegulatoryLifecycle
Gulfstream Intelligence is designed to supportregulatory teams throughout development, from monitoring changes in the globalregulatory environment and assessing program readiness to preparing for healthauthority interactions, developing global labeling and planning majorsubmissions.
As programs progress, information generated through thoseactivities can remain connected rather than becoming isolated across separatesystems and documents.
The result is a regulatory working environment designed togive teams greater visibility into what has changed, what it means for theirprogram, what needs attention and what needs to happen next.
About Gulfstream Intelligence
Gulfstream Intelligence is a regulatory intelligenceand execution platform developed by Gulfstream Life Science for pharmaceutical,biotechnology and life science organizations.
Created by regulatory professionals with more than 25years of industry experience, Gulfstream Intelligence brings together globalregulatory intelligence and policy, global labeling, regulatory gap assessment,health authority preparation and simulation, submission planning, regulatorydocument analysis and decision ready deliverables within one connectedenvironment.
The platform is designed to help regulatory teams navigateincreasingly complex global development programs while keeping experiencedregulatory professionals at the center of strategy and decision making.
Learn more: gulfstreamintelligence.com
Media Contact
Gulfstream Intelligence
Scott Morvay
[email protected]
gulfstreamintelligence.com